Green Fluorescent Protein (GFP) - originally found in a jellyfish - has played a crucial role in life science research, providing insights to many fundamental questions that have paved the way to the biology and medicine of the future. Since the mid-1990s, when the protein was successfully cloned, GFP can be found in research laboratories worldwide used as a visual marker of gene expression and protein localization, easily observed via light (optical) microscopy. GFP can be linked to other proteins and is primarily used to track dynamic changes in living cells. In 2008, biologists who discovered and developed the protein as a laboratory tool won a Nobel Prize for their work. Researchers in Spain have now demonstrated how GFP can also act as an efficient nano-thermometer inside cells.
Knowing the distribution of DNA binding proteins along the genome is very informative and can tell scientists about the state of gene expression at the time of measurement. These DNA-binding proteins include transcription factors which modulate the process of transcription, various polymerases, nucleases which cleave DNA molecules, and histones which are involved in chromosome packaging in the cell nucleus. Previously, researchers demonstrated the viability of a single-molecule approach to directly visualize and map protein binding sites on DNA using fluorescent quantum dots, allowing multicolor, nanometer-resolution localization. Now, they have shown that proteins bound to DNA can be located very accurately by direct imaging. The precision of these measurement presents new opportunities for contextual genomic research on the single-molecule level.
The Venus flytrap (Dionaea muscipula) is a carnivorous plant that catches and digests little insects. Its trapping mechanism consists of a series of tiny hairs at the crease where the plant's two leaves join. When a fly or spider walk across these hairs, touching two or more of them in succession, the two leaves will close quickly enough - within hundreds of milliseconds - to prevent its escape. Now, researchers have used it as inspiration for a new biomimetic robot made with artificial muscles. The device offers promise in the development of electrically stimulated artificial muscle that could be implanted in people to help overcome muscular disease or paralysis.
Early detection of food borne pathogenic bacteria is critical to prevent disease outbreaks and preserve public health. This has led to urgent demands to develop highly efficient strategies for isolating and detecting this microorganism in connection to food safety, medical diagnostics, water quality, and counter-terrorism. Conventional techniques to detect E. coli and other pathogenic bacteria are time-consuming, labor-intensive, and inadequate as they lack the ability to detect bacteria in real time. Thus, there is an urgent need for alternative platforms for the rapid, sensitive, reliable and simple isolation and detection pathogens. Taking a novel approach to isolating pathogenic bacteria from complex clinical, environmental and food samples, researchers have developed a nanomotor strategy that involves the movement of lectin-functionalized microengines. Receptor-functionalized nanoswimmers offer direct and rapid target isolation from raw biological samples without preparatory and washing steps.
Surface-enhanced Raman spectroscopy (SERS) is a powerful research tool that is being used to detect and analyze chemicals as well as a non-invasive tool for imaging cells and detecting cancer. It also has been employed for label-free sensing of bacteria, exploiting its tremendous enhancement in the Raman signal. SERS can provide the vibrational spectrum of the molecules on the cell wall of a single bacterium in a few seconds. Such a spectrum is like the fingerprints of the molecules and therefore could be exploited as a means to quickly identify bacteria without the need of a time-consuming bacteria culture process, which typically takes a few days to several weeks depending on the species of bacteria. To practically apply SERS to the early diagnosis of bacteremia - the presence of bacteria in the blood - researchers have managed to capture bacteria in a patient's blood onto the SERS substrate.
The integration of biological components with electronics, and more specifically, the interfacing of complex biological systems is one of the current challenges on the path towards bioelectronics (or bionics for short). Up to know, and due to its technology maturity, most of the work has been done based on Si-FET technology. However, there have been some issues related to this technology which prevented a more successful implementation into real applications. Researchers have now demonstrated, for the first time, that CVD grown graphene can be employed to fabricate arrays of transistors which are able to detect the electrical activity of electrogenic cells.
Breath analysis has been recognized as an increasingly accurate diagnostic method to link specific gaseous components in human breath to medical conditions and exposure to chemical compounds. Sampling breath is also much less invasive than testing blood, can be done very quickly, and creates as good as no biohazard waste. A recent review article in Environmental Science and Technology focuses on breath analysis as a tool for assessing environmental exposure and provides a good overview of the current state of diagnostic tools, leading studies in this field, and emerging technologies for hand-held breath analyzers. After describing the basics of breath analysis as a diagnostic tool, the authors discuss emerging chemical sensor technology ('electronic noses'), in particular two nanotechnology-based approaches, that are suitable to identify target analytes in breath.
Every aspect of cellular activities, including cell proliferation, differentiation, metabolism and apoptosis, can be regulated by a class of tiny but very important nucleic acids fragments called microRNAs (miRNAs). They bind to specific messenger RNAs and cause messenger RNA degradation or inhibit translation, thereby regulate gene expression at the post-translational level. In cancer cells, the homeostasis of these normal biological processes is disrupted, partially by dysregulated miRNAs, therefore the level of microRNAs is an indicator to the disease development, and miRNAs in cancer tissues or biofluids can be utilized as a diagnostic biomarker for cancer detection. Now, researchers report a miRNAs-based discovery that could provide a much earlier warning signal for lung cancer.